Insider Trading Activity AcelRx Pharmaceuticals (NASDAQ:ACRX) – CFO Bought 5,000 shares of Stock

Insider Trading Activity For AcelRx Pharmaceuticals (NASDAQ:ACRX)

Story continues below

Raffi Asadorian , CFO of AcelRx Pharmaceuticals (NASDAQ:ACRX) reportedly Bought 5,000 shares of the company’s stock at an average price of 3.18 for a total transaction amount of $15,900.00 SEC Form

Insider Trading History For AcelRx Pharmaceuticals (NASDAQ:ACRX)

  • On 12/7/2012 Mark A Wan, Director, bought 2,416,918 with an average share price of $3.31 per share and the total transaction amounting to $7,999,998.58.
  • On 5/28/2013 Adrian Adams, Director, bought 75,000 with an average share price of $8.19 per share and the total transaction amounting to $614,250.00.
  • On 6/6/2013 Mark G Edwards, Director, bought 10,000 with an average share price of $8.10 per share and the total transaction amounting to $81,000.00.
  • On 7/23/2013 Perceptive Advisors Llc, Major Shareholder, bought 850,000 with an average share price of $11.65 per share and the total transaction amounting to $9,902,500.00.
  • On 9/18/2013 Guy Nohra, Director, sold 128,780 with an average share price of $10.42 per share and the total transaction amounting to $1,341,887.60.
  • On 9/20/2013 Guy Nohra, Director, sold 158,153 with an average share price of $10.59 per share and the total transaction amounting to $1,674,840.27.
  • On 11/1/2013 Perceptive Advisors Llc, Major Shareholder, bought 360,660 with an average share price of $6.91 per share and the total transaction amounting to $2,492,160.60.
  • Analyst Ratings History For AcelRx Pharmaceuticals (NASDAQ:ACRX)

    • On 8/1/2017 Cowen Reiterated Rating Hold
    • On 8/9/2017 Stifel Nicolaus Upgraded rating Hold ➝ Buy
    • On 10/12/2017 Roth Capital Set Price Target of rating Buy with a price target of $8.00
    • On 10/13/2017 Jefferies Group Downgraded rating Buy ➝ Hold
    • On 10/13/2017 Royal Bank of Canada Lower Price Target of rating Outperform ➝ Outperform with a price target of $6.00 ➝ $5.00
    • On 10/13/2017 Piper Jaffray Companies Reiterated Rating Hold with a price target of $2.00
    • On 10/27/2017 HC Wainwright Reiterated Rating Buy with a price target of $5.00

    Recent Trading Activity for AcelRx Pharmaceuticals (NASDAQ:ACRX)
    Shares of AcelRx Pharmaceuticals closed the previous trading session at 3.20 +0.00 0.00% with 3.450000047683716 shares trading hands.

    An ad to help with our costs